1-20 of 406
Health Services and Outcomes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biomarker signatures for sickle cell pain

Open Access
Clinical Trials & Observations
Kalpna Gupta, Vidhya Kumaresan
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3821–3823.
https://doi.org/10.1182/bloodadvances.2025016707
Published: 2025
Journal Articles

Accelerating Novel Therapies for Sickle Cell Disease with RWE: ASH RC Data Hub as a Strategically Coordinated Registry Network

Open Access
William A Wood, Osman N Yogurtcu, Emily Semmel, Kathleen Torres (formerly Hewitt), Donna S. Neuberg, Lea B Witkowsky, Ken Taymor, Santiago J Molina, Jane S Hankins, Alexis A. Thompson, Gregory Pappas
Journal: Blood Advances
Blood Adv bloodadvances.2024015532.
https://doi.org/10.1182/bloodadvances.2024015532
Published: 2025
Includes: Supplemental data
Journal Articles

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

Open Access
Zachary D Epstein-Peterson, Anath Christopher Lionel, Ashlee Joseph, Esther Drill, Suheil Albert Atallah-Yunes, Taylor R Brooks, Elise A. Chong, Emeline R Chong, Jamie Dela Cruz, Matthew J Frank, Andrew Ip, Madiha Iqbal, Caron A. Jacobson, Manali Kamdar, Reem Karmali, Ofrat Beyar-Katz, Kami J Maddocks, Matthew J. Matasar, Daniel McLoughlin, Reid W Merryman, Javier Munoz, Rohin Navalekar, Joanna M Rhodes, Peter A. Riedell, Christine E Ryan, Gilles A. Salles, Craig S. Sauter, Yazeed Sawalha, Samanvaya Sharma, Roni Shouval, Navika Shukla, Dylan Therwhanger, Herman J van Besien, Ben Varon, Yucai Wang, Samuel Yamshon, Andrew D. Zelenetz, M. Lia Palomba, Preetesh Jain, Anita Kumar
Journal: Blood Advances
Blood Adv bloodadvances.2025016315.
https://doi.org/10.1182/bloodadvances.2025016315
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

Open Access
Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S. Firestone, Eric M. Jurgens, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Andriy Derkach, David Nemirovsky, Sergio A. Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi
Journal: Blood Advances
Blood Adv (2025) 9 (15): 4016–4022.
https://doi.org/10.1182/bloodadvances.2025015973
Published: 2025
Journal Articles

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

Open Access
Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, Paolo Mazzeo, Rebecca Wurm-Kuczera, Vladan Vucinic, Udo Holtick, Hristo Boyadzhiev, Thomas Melchardt, Alexander Hölscher, Christian Schultze-Florey, Atef Abdelhafez, Giuliano Filippini Velazquez, Anna Ossami Saidy, Vadim Lesan, Ulf Schnetzke, Andrea Kerkhoff, Ulrike Bacher, Susanne Ghandili, Enver Aydilek, Niklas Gebauer, Thomas Weber, Gerald Wulf, Bertram Glass, Lorenz Thurner, Florian H. Heidel, Christoph Schmid, Andreas Viardot, Mathias Hänel, Sascha Dietrich, Thomas Pabst, Francis Ayuk, Bastian von Tresckow, Björn Chapuy, Christiane Pott, Fabian Müller, Georg Lenz
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3955–3966.
https://doi.org/10.1182/bloodadvances.2024015719
Published: 2025
Includes: Supplemental data
Journal Articles

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients

Open Access
Brandyn D. Lau, Aditya Bhave, Jennifer C. Yui, Rakhi Naik, Kathryn E. Dane, John Lindsley, Dauryne L. Shaffer, Peggy S. Kraus, Erik H. Hoyer, Elliott R. Haut, Michael B. Streiff
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3929–3936.
https://doi.org/10.1182/bloodadvances.2024015306
Published: 2025
Includes: Supplemental data
Journal Articles

The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component

Open Access
Clinical Trials & Observations
Kari A. O. Tikkinen, Deborah M. Siegal, P. J. Devereaux, Sara V. Tornberg, Flavia K. Borges, Sandra Ofori, Jehonathan Pinthus, Bobby Shayegan, Lauri I. Lavikainen, Gordon H. Guyatt, Pavel S. Roshanov
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3837–3844.
https://doi.org/10.1182/bloodadvances.2024015515
Published: 2025
Journal Articles

Molecular inflammatory expression profiles associated with the frequency of pain in individuals with sickle cell disease

Open Access
Clinical Trials & Observations
Lana Mucalo Katunaric, Shuang Jia, Ashima Singh, Mark F. Roethle, Julie A. Panepinto, David C. Brousseau, Martin J. Hessner, Amanda M. Brandow
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3790–3800.
https://doi.org/10.1182/bloodadvances.2024015085
Published: 2025
Includes: Supplemental data
Journal Articles

Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL

Open Access
Clinical Trials & Observations
John N. Allan, Tao Ran, Zhijie Ding, Jinghua He, Alex Bokun, Zaina P. Qureshi, Susan M. O’Brien
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3801–3809.
https://doi.org/10.1182/bloodadvances.2024015417
Published: 2025
Journal Articles

Estimation of Benefit to Bispecific Antibodies in US Patients with Lymphoma and Multiple Myeloma

Open Access
Fausto Alfredo Rios-Olais, Talal Hilal
Journal: Blood Advances
Blood Adv bloodadvances.2025016176.
https://doi.org/10.1182/bloodadvances.2025016176
Published: 2025
Includes: Supplemental data
Journal Articles

Evaluating the long-term benefits of hydroxyurea in pediatric sickle cell anemia

Open Access
Paul George, Grace Kalmus, Peter A. Lane, Wilbur Lam, Joseph Lipscomb, David Howard
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3585–3593.
https://doi.org/10.1182/bloodadvances.2024015564
Published: 2025
Includes: Supplemental data
Journal Articles

Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials

Open Access
Ahmad Y. Abuhelwa, Sara A. Almansour, Jennifer R. Brown, Humaid O. Al-Shamsi, Ziad Abuhelwa, Zelal Kharaba, Yasser Bustanji, Mohammad H. Semreen, Salma Ali, Ahmad Alhuraiji, Ross A. McKinnon, Michael J. Sorich, Karem H. Alzoubi, Ashley M. Hopkins
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3566–3575.
https://doi.org/10.1182/bloodadvances.2024015287
Published: 2025
Includes: Supplemental data
Journal Articles

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

Open Access
Anmol Baranwal, Kimberly J. Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich, Caner Saygin, Mariam Nawas, Talha Badar, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Vivek Roy, James M. Foran, Hemant S. Murthy, Madiha Iqbal, Jeanne Palmer, Lisa Z. Sproat, Saurabh Chhabra, Nandita Khera, Mehrdad Hefazi, Abhishek Mangaonkar, William Hogan, Mark Litzow, Hassan Alkhateeb, Ayalew Tefferi, Chung Hoow Kok, Guru Subramanian Guru Murthy, Anand Patel, Ashish Bajel, Devendra K. Hiwase, Mithun Vinod Shah
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3395–3407.
https://doi.org/10.1182/bloodadvances.2024015335
Published: 2025
Includes: Supplemental data
Journal Articles

Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis

Open Access
Karthik Nath, Mei-Jie Zhang, Matthew Bye, Muhammad Bilal Abid, Cara Benjamin, Brian Betts, Neel S. Bhatt, Esteban Arrieta Bolaños, Yung-Tsi Bolon, Shahinaz M. Gadalla, Michael R. Grunwald, Maxwell M. Krem, Stephanie J. Lee, Steven G. E. Marsh, Rodrigo Martino, Parinda A. Mehta, Filippo Milano, Timothy Prestidge, Jennifer N. Saultz, Bronwen E. Shaw, Stephen R. Spellman, Hannah Choe, Brian C. Shaffer
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3469–3478.
https://doi.org/10.1182/bloodadvances.2024014858
Published: 2025
Includes: Supplemental data
Journal Articles

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

Open Access
Emily Sirotich, Saifur R. Chowdhury, Dimpy Modi, Gordon Guyatt, Melanie St John, Kerolos Eisa, Adam Cuker, Carolyn E. Beck, Rachael F. Grace, Justin W. Yan, Shuoyan Ning, Charles T. Quinn, Amanda Pfeiffer, Michele P. Lambert, Karen Panckeri, Allyson Pishko, Kristine VanAarsen, Ahmed Slim, Kathryn Carrier, Rebecca Geer, Abinaya Arulselvan, Matthew Basara, Brenna Cannon, Ellis J. Bloom, Sam J. King, Daya Gill, Laura M. Venier, Emily Xu, Ishaq Siddiqui, Bonnie Liu, Timothy Mercier, Taylah Buissereth, Emily M. Harris, Enass H. Raffa, Joel Livingston, Mahmudur Rahman Chowdhury, Maryam Akbari-Moghaddam, Dongyoung Kim, Lehana Thabane, Dena Zeraatkar, Donald M. Arnold
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3238–3248.
https://doi.org/10.1182/bloodadvances.2024015494
Published: 2025
Journal Articles

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Open Access
Clinical Trials & Observations
Mohamed L. Sorror, Wael Saber, Brent Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Lori Jarrett, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R. McCurdy, Lawrence E. Morris, Philip H. Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew S. Artz
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3268–3280.
https://doi.org/10.1182/bloodadvances.2025015793
Published: 2025
Includes: Supplemental data
Journal Articles

Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

Open Access
Nikhil Yegya-Raman, John P. Plastaras, Christopher M. Wright, Monica Chelius, Siqi Zhang, Jonathan A. Baron, Harper Hubbeling, Austin J. Sim, Timothy J. Robinson, Michael D. Jain, Brandon Imber, Beatrice Fregonese, Joachim Yahalom, Colton Ladbury, Savita Dandapani, Chelsea C. Pinnix, Jillian R. Gunther, Penny Q. Fang, Susan Y. Wu, Bouthaina S. Dabaja, Joanna C. Yang, Jessica Chew, Steve Braunstein, Sumi Sinha, Nathan M. Delinger, Susan Sun, Stephanie A. Terezakis, Gukan Sakthivel, Louis S. Constine, Amit K. Chowdhry, Patrick M. Reagan, Skyler Burke, Yolanda D. Tseng, Michael J. LaRiviere, Amit Maity, Stephen J. Schuster, Elise A. Chong, Nicholas B. Figura
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3293–3303.
https://doi.org/10.1182/bloodadvances.2025015855
Published: 2025
Includes: Supplemental data
Journal Articles

Moving Beyond The Eyeball Test for Fitness Assessment in AML

Open Access
Samuel J. Yates, Heidi D. Klepin
Journal: Blood Advances
Blood Adv bloodadvances.2025016235.
https://doi.org/10.1182/bloodadvances.2025016235
Published: 2025
Journal Articles

A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease

Open Access
Shalini Shenoy, Julie Kanter, Adetola Kassim, Courtney Fitzhugh, Elizabeth Stenger, Monica Bhatia, Lydia Pecker, Lakshmanan Krishnamurti, Allison A. King
Journal: Blood Advances
Blood Adv (2025) 9 (12): 3090–3103.
https://doi.org/10.1182/bloodadvances.2024013953
Published: 2025
Includes: Supplemental data
Journal Articles

A Mixed Methods Study to Understand the Role of Knowledge in Transition among Youth with Sickle Cell Disease

Open Access
Ashima Singh, Mahua Dasgupta, M. Muska Nataliansyah, Nicole Steiner, Jeff Karst, Meghan Miller, Joshua J Field, Melissa Azul, Liliana E. Pezzin, Amanda M. Brandow
Journal: Blood Advances
Blood Adv bloodadvances.2025015984.
https://doi.org/10.1182/bloodadvances.2025015984
Published: 2025
Includes: Supplemental data